Acadia Healthcare Company's Price Target Lowered Amid Softer Medicaid Trends and Higher Bad Debt

Acadia Healthcare Company's stock price target has been revised by analysts, with RBC Capital lowering its target to $22 from $28 due to softer Medicaid trends and higher bad debt. Despite this, the firm maintains a positive rating, citing confidence in Acadia's long-term execution and growth prospects. Engine Capital has acquired a 3% stake in Acadia and is pressing for operational changes, asset sales, and share repurchases amidst ongoing investigations into patient care and billing practices.